{
  "retracted": false,
  "timestamp": 1579564800000,
  "updates": [
    {
      "timestamp": 1591730464560,
      "identifier": {
        "doi": "10.1007/s40273-020-00885-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.2165/11595080-000000000-00000"
  },
  "journal": "PharmacoEconomics",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes"
}
